[Ru(phen)2(HMPIP)](PF6)2 (Compound 6A) is an antitumor agent that inhibits the proliferation and migration of liver cancer cells (HepG2), while inducing apoptosis, autophagy, cell cycle arrest, and ferroptosis. It enhances antitumor activity by stimulating immune response, leading to an increase in CD8+ T cells.
Target:
Autophagy|||Apoptosis|||Ferroptosis
* VAT and and shipping costs not included. Errors and price changes excepted
